Guanzhen Wang

590 citations
17 papers · 391 indexed · h-index 9

Impact in

Papers in

Guanzhen Wang

16 papers receiving 385 citations

Peers

Guanzhen Wang
Comparison fields: 5 of 103
  • Infectious Diseases 121
  • Neurology 54
  • Biochemistry 20
  • Oncology 64
  • Obstetrics and Gynecology 18
Replace Can Xu with:
Can Xu China
Lijun Pang China
Dan Cao China
Fatemeh Sadoughi Iran
Shun‐Hsing Hung Taiwan
Hamid‐Reza Mohammadi‐Motlagh Iran
Naveen Kumar Vishvakarma India
Ruijuan Liu China
Mitra Abbasifard Iran
Guanzhen Wang relative to Can Xu China Can Xu's profile →
Citations per field
00.5×1.5×
Can Xu · 1×
Citations per year

Countries citing papers authored by Guanzhen Wang

Since Specialization
Citations

This map shows the geographic impact of Guanzhen Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guanzhen Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guanzhen Wang more than expected).

Fields of papers citing papers by Guanzhen Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guanzhen Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guanzhen Wang. The network helps show where Guanzhen Wang may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Guanzhen Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Guanzhen Wang Line = papers co-authored together Guanzhen Wang links everyone, so they are left out of the graph.

All Works

17 of 17 papers shown
#Work
1 20250
2 20239
3 20232
4 20223
5 20229
6 202214
7 202282
8 20227
9 202232
10 202116
11 20208
12 2020139
13 20202
14 20191
15 201917
16 201946
17 20104

About Guanzhen Wang

Guanzhen Wang is a scholar working on Aging, Hepatology, Critical Care and Intensive Care Medicine, Biochemistry and Microbiology, having authored 17 papers that have together received 391 indexed citations. Recurring topics across this work include Advanced biosensing and bioanalysis techniques (4 papers), Liver Disease Diagnosis and Treatment (3 papers), Natural product bioactivities and synthesis (3 papers), Liver physiology and pathology (2 papers), Phytochemistry and Biological Activities (2 papers), Supramolecular Self-Assembly in Materials (2 papers), Pancreatic function and diabetes (2 papers) and Image and Signal Denoising Methods (1 paper). The work is most often cited by research in Infectious Diseases (121 citations), Neurology (54 citations), Biochemistry (20 citations), Oncology (64 citations) and Obstetrics and Gynecology (18 citations). Guanzhen Wang has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Wei Liu, Tingdong Yan, Wei Gu, Xiaomei Zhang, Feng Shao, Rongrong Deng, Chengbin Li, Xiao Ding, Tao Li and Changzheng Wang. Their work appears in journals such as Oxidative Medicine and Cellular Longevity, Evidence-based Complementary and Alternative Medicine, Journal of the American Chemical Society, Frontiers in Bioengineering and Biotechnology and Frontiers in Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026